Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
60 | $28.55 | $1,713 | 11,495 (Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
60 | $28.54 | $1,712 | 11,883 (Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
73 | $28.53 | $2,083 | 18,536 (Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
62 | $28.54 | $1,769 | 14,836 (Indirect Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
198 | $28.54 | $5,651 | 45,966 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
194 | $6.52 | $1,265 | 2,030 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
214 | $6.51 | $1,393 | 2,098 (Indirect Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
194 | $6.51 | $1,263 | 2,418 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
261 | $6.51 | $1,699 | 5,809 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
561 | $6.52 | $3,658 | 4,464 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:12 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
2,613 | $0.37 | $967 | 111,203 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:12 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
2,613 | $0.37 | $967 | 130,595 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:11 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
3,144 | $0.37 | $1,163 | 285,201 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:10 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
3,092 | $0.37 | $1,144 | 115,541 (Indirect Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:09 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,975 | $0.37 | $2,951 | 251,183 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
113,629 | $0 | 149,623 (Direct) |
View |
2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
12,430 | $0 | 188,967 (Direct) |
View |
2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
370,704 | $0 | 488,385 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director |
2,502 | $0 | 3,564 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director |
1,600 | $0 | 1,600 (Direct) |
View |
2023-03-10 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
9,625 | $0 | 25,064 (Direct) |
View |
2022-02-15 Other |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
9 | $0 | 25,064 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
1,738 | $0 | 2,538 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
15,639 | $0 | 27,134 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director |
1,640 | $0 | 1,640 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director |
2,197 | $0 | 3,257 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
14,736 | $0 | 26,619 (Direct) |
View |
2023-03-10 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
69,784 | $0 | 8,156 (Direct) |
View |
2023-02-15 Other |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
73 | $0 | 8,156 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
17,916 | $0 | 36,452 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
21,158 | $0 | 35,994 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
71,715 | $0 | 117,681 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
432 | $0 | 432 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
432 | $0 | 432 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
432 | $0 | 432 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
576 | $0 | 576 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
576 | $0 | 576 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
1,512 | $0 | 1,512 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
9,525 | $0 | 15,439 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
9,525 | $0 | 11,495 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
9,525 | $0 | 11,883 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
12,800 | $0 | 18,536 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
12,800 | $0 | 14,836 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
41,700 | $0 | 45,966 (Direct) |
View |
2022-10-31 Option Award |
2022-11-01 4:12 pm |
N/A 2032-10-30 |
Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director |
1,600 | $0 | 1,600 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:46 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director |
40,000 | $0 | 40,000 (Direct) |
View |